Determinants of the response of neuroblastoma cells to DNA damage: The roles of pre-treatment cell morphology and chemical nature of the damage

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 1158-1166

  Hartsell, Theresa L ^a   Hinman, Lois M ^b   Hamann, Philip R ^b   Schor, Nina Felice ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALICHEAMICIN; CISPLATIN; DYNEMICIN A; ESPERAMICIN A1; ETOPOSIDE; TOPOTECAN; ZINOSTATIN;

APOPTOSIS; ARTICLE; CELL STRUCTURE; DNA CLEAVAGE; DNA DAMAGE; HUMAN; HUMAN CELL; NEURAL CREST CELL; NEUROECTODERM; PRIORITY JOURNAL; SCHWANN CELL;

APOPTOSIS; DNA; DNA DAMAGE; HUMANS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, NERVE GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ZINOSTATIN;

EID: 0030435331     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AZAR C., SCARVADA N. J., REYNOLDS C. P. AND BRODEUR G. M.: Multiple defects of the nerve growth factor receptor in human neuroblastomas. Prog. Clin. Biol. Res. 3.366: 219-226, 1991.
2. BIEDLER J. L., HELSON L AND SPENGLER B. A.: Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33: 2643-2662, 1973.
3. CHIOU S. K., RAO L AND WHITE E.: Bcl-2 blocks p53-dependent apoptosis. Mol. Cell Biol. 14: 2556-2563, 1994.
4. CICCARONE V., SPENGLER B. A., MEYERS M. B., BIEDLER J. L. AND ROSS R. A.: Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res. 49: 219-225, 1989.
5. COTTER T. G., LENNON S. V., GLYNN J. G. AND MARTIN S. J.: Cell death via apoptosis and its relationship to growth, development, and differentiation of both tumor and normal cells. Anticancer Res. 10: 1153-1160, 1990.
6. DOLE M., NUNEZ G., MERCHANT A. K., MAYBAUM J., RODE C. K., BLOCH C. A. AND CASTLE V. P.: Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54: 3253-3259, 1994.
7. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55: 2576-2582, 1995.
8. EVANS D. L AND DIVE C.: Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res. 53: 2133-2139, 1993.
9. FALCIONE M., MILLIGAN K. D., SCHWARTZ M. C. AND SCHOR N. F.: Prevention of neocarzinostatin-induced cell death and morphologic change in SK-N-SH human neuroblastoma cells by continuous exposure to nerve growth factor. Biochem. Pharm. 46: 731-738, 1993.
10. GOLDBERG I. H.: Mechanism of neocarzinostatin: Role of DNA microstructure in determination of chemistry of bistranded oxidative damage. Accounts Chem. Res. 24: 191-198, 1991.
11. HARTSELL T. L., YALOWICH J. C., RITKE M. K., MARTINEZ A. J. AND SCHOR N. F.: Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin. J. Pharmacol. Exp. Ther. 275: 479-485, 1995.
12. HICKMAN J. A.: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11: 121-139, 1992.
13. HINMAN L. M., HAMANN P. R., WALLACE R , MENENDEZ A. T., DURR F. E. AND UPESLACIS J.: Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: A novel and potent family of antitumor antibiotics. Cancer Res. 53: 3336-3342, 1993.
14. HOOPER M. L.: The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J. Cell Sci. Suppl. 18: 13-17, 1994.
15. KANE D. J., SARAFIAN T. A., ANTON R., HAHN H., GRALLA E. B., VALENTINE J. S., ORD T. AND BREDESEN D. E.: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science (Wash. DC) 262: 1274-1277, 1993.
16. KAPPEN L. S., NAPIER M. A. AND GOLDBERG I. H.: Roles of chromophore and apo-protein in neocarzinostatin action. Proc. Natl. Acad. Sci. USA 77: 1970-1974, 1980.
17. KORSMEYER S. J., SHUTTER J. R., VEIS D. J., MERRY D. E. AND OLTVAI Z. N.: Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4: 327-332, 1993.
18. LOTEM J. AND SACHS L.: Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ. 4: 41-47, 1993.
19. LOWE S. W., RULEY H E , JACKS T. AND HOUSMAN D. E.: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
20. NICOLAOU K. C., STABILA P., ESMAELI-AZAD B., WRASIDLO W. AND HIATT A.: Cell-specific regulation of apoptosis by designed enediynes. Proc. Natl. Acad. Sci. USA 90: 3142-3146, 1993.
21. OLTVAI Z. N., MILLIMAN C. L. AND KORSMEYER S. J.: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
22. PLEASURE S. J., REDDY U. R., VENKATAKRISHNAN G., ROY A. K., CHEN J., ROSS A. H., TROJANOWSKI J. Q., PLEASURE D. E. AND LEE V. M.: Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high- and low-affinity NGF receptors but not NGF-mediated differentiation. Proc. Natl. Acad. Sci. USA 87: 8496-8500, 1990.
23. RABIZADEH S., OH J., ZHONG L-T., YANG J., BITLER C. M., BUTCHER L. L. AND BREDESEN D. E.: Induction of apoptosis by the low-affinity NGF receptor. Science (Wash. DC) 261: 345-348, 1993.
24. RAFF M. C.: Social controls on cell survival and cell death. Nature (Lond.) 356: 397-400, 1992.
25. REED J. C., MEISTER L., TANAKA S., CUDDY M., YUM S., GEYER C. AND PLEASURE D.: Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 51: 6529-6538, 1991.
26. RETTIG W. J., SPENGLER B. A., CHESA P. G., OLD L. J. AND BIEDLER J. L.: Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 47: 1383-1389, 1987.
27. ROSS R. A., SPENGLER B. A. AND BIEDLER J. L.: Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71: 741-747, 1983.
28. SAYLORS R. L., III, SIDRANSKY D., FRIEDMAN H. S., BIGNER S. H., BIGNER D. D., VOGELSTEIN B. AND BHODEUR G. M.: Infrequent p53 gene mutations in medulloblastomas. Cancer Res. 51: 4721-4723, 1991.
29. SCHOR N. F.: Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture. J. Pharmacol. Exp. Ther. 249: 906-910, 1989.
30. SHIRAKI T. AND SUGIURA Y.: Visible light induced DNA cleavage by the hybrid antitumor antibiotic dynemicin A. Biochemistry 29: 9796-9798, 1990.
31. STRASSER A., HARRIS A. W., JACKS T. AND CORY S.: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79: 329-339, 1994.
32. UESAWA Y., KUWAHARA J. AND SUGIURA Y.: Light-induced DNA cleavage by esperamicin and neocarzinostatin. Biochem. Biophys. Res. Commun. 164: 903-911, 1989.
33. WYLLIE A. H.: Apoptosis and the regulation of cell numbers in normal and neoplastic tissue: An overview. Cancer Metastasis Rev. 11: 95-103, 1992
34. 1: An antitumor antibiotic that cleaves double-stranded DNA site specifically. Science (Wash DC) 240: 1198-1201, 1988.